Clinical Trial Update: Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

View source ↗

Summary

An observational safety study evaluating ADASUVE (loxapine inhalation powder) for agitation associated with schizophrenia or Bipolar I disorder has been suspend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Adasuve (loxapine)

Snippet

Sponsor: Alexza Pharmaceuticals, Inc. | Conditions: Agitation,Psychomotor | Status: SUSPENDED